Tracking AI/LLM Literacy and Knowledge in Urology Outpatients (TALK-U)
Condition(s) studied
Study summary
This study is a one-time, questionnaire-based survey of adults attending a urology outpatient clinic. The investigators will examine whether patients who use AI chat tools based on large language models (LLMs), such as ChatGPT, before seeking care differ from non-users in (1) anxiety, (2) satisfaction with the clinic visit, and (3) awareness/understanding of their health condition.
Participants who provide written informed consent will complete a brief survey during their clinic visit (about 5-7 minutes). The survey includes a standardized anxiety scale (GAD-7), visual analog scales (0-10) for anxiety before and after the visit, satisfaction, and disease awareness, as well as questions about AI/LLM knowledge and use. Treating clinicians will not have access to participants' survey responses, and participation will not affect clinical care.
Eligibility
Primary outcome measure(s)
- Pre-visit Anxiety (VAS 0-10) — Day 0 (immediately before the outpatient visit)
Self-rated anxiety on a 0-10 visual analog scale (VAS), where 0 indicates no anxiety and 10 indicates the highest possible anxiety. This measure reflects visit-related state anxiety prior to clinician encounter.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Dr.Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital | Ankara | Yenimahalle/Ankara |
More Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital trials in Turkey
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07325617 on ClinicalTrials.gov ↗ ← All trials in Turkey